- Home
- FATBB vs IFRX Comparison
FATBB vs IFRX Comparison
Compare FATBB & IFRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FATBB
- IFRX
- Stock Information
- Founded
- FATBB 2017
- IFRX 2007
- Country
- FATBB United States
- IFRX Germany
- Employees
- FATBB N/A
- IFRX N/A
- Industry
- FATBB Restaurants
- IFRX Biotechnology: Pharmaceutical Preparations
- Sector
- FATBB Consumer Discretionary
- IFRX Health Care
- Exchange
- FATBB Nasdaq
- IFRX Nasdaq
- Market Cap
- FATBB 46.5M
- IFRX 53.5M
- IPO Year
- FATBB N/A
- IFRX 2017
- Fundamental
- Price
- FATBB $2.60
- IFRX $1.65
- Analyst Decision
- FATBB
- IFRX Strong Buy
- Analyst Count
- FATBB 0
- IFRX 5
- Target Price
- FATBB N/A
- IFRX $7.40
- AVG Volume (30 Days)
- FATBB 2.7K
- IFRX 802.1K
- Earning Date
- FATBB 01-01-0001
- IFRX 08-07-2025
- Dividend Yield
- FATBB 5.38%
- IFRX N/A
- EPS Growth
- FATBB N/A
- IFRX N/A
- EPS
- FATBB N/A
- IFRX N/A
- Revenue
- FATBB $577,500,000.00
- IFRX $191,224.00
- Revenue This Year
- FATBB N/A
- IFRX N/A
- Revenue Next Year
- FATBB $7.74
- IFRX $1,336.36
- P/E Ratio
- FATBB N/A
- IFRX N/A
- Revenue Growth
- FATBB 0.96
- IFRX 54.36
- 52 Week Low
- FATBB $2.10
- IFRX $0.71
- 52 Week High
- FATBB $5.18
- IFRX $2.82
- Technical
- Relative Strength Index (RSI)
- FATBB 49.81
- IFRX 76.92
- Support Level
- FATBB $2.44
- IFRX $1.45
- Resistance Level
- FATBB $2.61
- IFRX $1.82
- Average True Range (ATR)
- FATBB 0.13
- IFRX 0.15
- MACD
- FATBB -0.00
- IFRX 0.08
- Stochastic Oscillator
- FATBB 31.58
- IFRX 83.00
About FATBB FAT Brands Inc. Class B
FAT Brands Inc is a multi-brand restaurant franchising company. It develops, markets, acquires, and manages quick service, fast casual, casual dining, and polished casual dining restaurant concepts around the world. The company operates as a franchisor of restaurants, where the company generally does not own or operate the restaurant locations but rather generates revenue by charging franchisees an initial franchise fee as well as ongoing royalties. For some of the company's brands, it also directly owns and operates restaurant locations. Its brands include Round Table Pizza, Fatburger, Johnny Rockets, Twin Peaks, and Elevation Burger among others. Geographically, the majority of the revenue for the company is generated from the United States.
About IFRX InflaRx N.V.
InflaRx NV is a clinical-stage biopharmaceutical company focused on applying proprietary anti-C5a/C5aR technology to discover and develop first-in-class, potent, and specific inhibitors of the complement activation factor known as C5a and its receptor known as C5aR. C5a is an inflammatory mediator involved in the progression of a wide variety of autoimmune and other inflammatory diseases. Its product candidate, vilobelimab, is a novel intravenously delivered first-in-class anti-C5a monoclonal antibody that selectively binds to free C5a and has demonstrated disease-modifying clinical activity and tolerability in multiple clinical settings.